BIOMAT Database Logo BIOMAT Database Logo

Circulating platelet aggregates in patients with coronary heart disease and lower limb ischaemia. 1985

M Popadić, and M Haracić, and D Rezaković, and L Pirnat

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001157 Arterial Occlusive Diseases Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. Arterial Obstructive Diseases,Arterial Occlusion,Arterial Obstructive Disease,Arterial Occlusions,Arterial Occlusive Disease,Disease, Arterial Obstructive,Disease, Arterial Occlusive,Obstructive Disease, Arterial,Occlusion, Arterial,Occlusive Disease, Arterial

Related Publications

M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Elevated mitochondrial membrane potential of circulating monocyte-platelet aggregates in patients with coronary heart disease.
February 2015, International journal of cardiology,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
February 1998, Journal of the American College of Cardiology,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease.
February 2005, The American journal of cardiology,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Do patients with thromboembolic disease have circulating platelet aggregates?
July 1984, Blood,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Platelet function and exercise-induced myocardial ischaemia in coronary heart disease patients.
October 1989, Thrombosis research,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Circulating platelet-leukocyte aggregates in patients with inflammatory bowel disease.
April 2013, Journal of the Chinese Medical Association : JCMA,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Production of circulating platelet aggregates by exercise in coronary patients.
January 1980, Circulation,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span.
March 1980, Thrombosis research,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Increased circulating platelet aggregates and coagulation factors in patients with Blackfoot disease.
July 1983, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
M Popadić, and M Haracić, and D Rezaković, and L Pirnat
Platelet function studies in coronary heart disease: VIII. Decreased platelet sensitivity to prostacyclin in patients with myocardial ischaemia.
January 1980, Thrombosis research,
Copied contents to your clipboard!